Advanced Registry Search Results

Search Criteria
  1. Lobbyist name (consultant or in-house lobbyist): WILLIAMS, COLLETTE OR;
  2. Senior Officer name: WILLIAMS, COLLETTE
Start over
Modify criteria
Refine By
Document Type Registrations Status Activity Type Subject Matter of the Lobbying Activity Ministries/Provincial Entities

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Advanced Registry Search Results

Results: 1-20 of 20
  1. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher, Country President & Oncology GM Canada
    Registration: 27 of 37 (2022-05-09 to 2022-05-09)
    Posted: 2022-05-09
    Subject matter details: 7
    Ministries/Provincial entities: 8
    Gifts or Benefits Provided: No
    Government funding: No
    Employees who lobby: 9
  2. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher, Country President & Oncology GM Canada
    Registration: 28 of 37 (2022-05-09 to 2022-06-01)
    Posted: 2022-05-09
    Subject matter details: 8
    Ministries/Provincial entities: 8
    Gifts or Benefits Provided: No
    Government funding: No
    Employees who lobby: 9
  3. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher, Country President & Oncology GM Canada
    Registration: 26 of 37 (2022-03-15 to 2022-05-09)
    Posted: 2022-03-16
    Subject matter details: 9
    Ministries/Provincial entities: 8
    Gifts or Benefits Provided: No
    Government funding: No
    Employees who lobby: 9
  4. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher, Country President & Oncology GM Canada
    Registration: 25 of 37 (2021-07-01 to 2022-03-15)
    Posted: 2021-07-14
    Subject matter details: 6
    Ministries/Provincial entities: 8
    Gifts or Benefits Provided: No
    Government funding: No
    Employees who lobby: 8
  5. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher, Country President & Oncology GM Canada
    Registration: 24 of 37 (2021-06-16 to 2021-07-01)
    Posted: 2021-06-16
    Subject matter details: 6
    Ministries/Provincial entities: 8
    Gifts or Benefits Provided: No
    Government funding: No
    Employees who lobby: 8
  6. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher, Country President & Oncology GM Canada
    Registration: 23 of 37 (2020-11-20 to 2021-06-16)
    Posted: 2020-12-11
    Subject matter details: 5
    Ministries/Provincial entities: 4
    Gifts or Benefits Provided: No
    Government funding: No
    Employees who lobby: 7
  7. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher, Country President & Oncology GM Canada
    Registration: 22 of 37 (2020-08-05 to 2020-11-20)
    Posted: 2020-08-05
    Subject matter details: 2
    Ministries/Provincial entities: 4
    Gifts or Benefits Provided: No
    Government funding: No
    Employees who lobby: 5
  8. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher, Country President & Oncology GM Canada
    Registration: 21 of 37 (2020-06-15 to 2020-08-05)
    Posted: 2020-06-15
    Subject matter details: 3
    Ministries/Provincial entities: 4
    Gifts or Benefits Provided: No
    Government funding: No
    Employees who lobby: 4
  9. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher, Country President & Oncology GM Canada
    Registration: 20 of 37 (2020-05-04 to 2020-06-15)
    Posted: 2020-06-08
    Subject matter details: 2
    Ministries/Provincial entities: 4
    Gifts or Benefits Provided: No
    Government funding: No
    Employees who lobby: 4
  10. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Christian Macher
    Registration: 19 of 37 (2020-03-17 to 2020-05-04)
    Posted: 2020-03-18
    Subject matter details: 1
    Lobbying target types: 1
    Government funding: No
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  11. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Geoffrey Squires
    Registration: 18 of 37 (2019-08-26 to 2020-02-26)
    Posted: 2019-08-26
    Subject matter details: 1
    Lobbying target types: 4
    Government funding: No
    Employees who lobby: 4
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  12. Novartis Pharmaceuticals Canada Inc.
    Activity type: Organization
    Senior Officer: Geoffrey Squires
    Registration: 17 of 37 (2019-02-22 to 2019-08-22)
    Posted: 2019-02-22
    Subject matter details: 1
    Lobbying target types: 4
    Government funding: No
    Employees who lobby: 9
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  13. AstraZeneca Canada Inc.
    Activity type: Organization
    Senior Officer: Jamie Freedman
    Registration: 17 of 32 (2019-02-04 to 2019-08-04)
    Posted: 2019-02-04
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  14. AstraZeneca Canada Inc.
    Activity type: Organization
    Senior Officer: Jamie Freedman
    Registration: 16 of 32 (2018-08-01 to 2019-02-01)
    Posted: 2018-08-01
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  15. AstraZeneca Canada Inc.
    Activity type: Organization
    Senior Officer: Jamie Freedman
    Registration: 15 of 32 (2018-01-26 to 2018-07-26)
    Posted: 2018-01-26
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 6
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  16. AstraZeneca Canada Inc.
    Activity type: Organization
    Senior Officer: Jamie Freedman
    Registration: 14 of 32 (2017-07-25 to 2018-01-25)
    Posted: 2017-07-25
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 7
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  17. Hoffmann-La Roche Limited
    Activity type: Organization
    Senior Officer: Ronnie Miller
    Registration: 13 of 32 (2017-04-26 to 2017-10-23)
    Posted: 2017-04-28
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 11
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  18. AstraZeneca Canada Inc.
    Activity type: Organization
    Senior Officer: Ed Dybka
    Registration: 13 of 32 (2017-01-17 to 2017-07-16)
    Posted: 2017-01-17
    Subject matter details: 1
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 7
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  19. Hoffmann-La Roche Limited
    Activity type: Organization
    Senior Officer: Ronnie Miller
    Registration: 11 of 32 (2016-04-20 to 2016-10-17)
    Posted: 2016-04-20
    Subject matter details: 2
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 7
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
  20. Hoffmann-La Roche Limited
    Activity type: Organization
    Senior Officer: Ronnie Miller
    Registration: 10 of 32 (2015-10-07 to 2016-04-04)
    Posted: 2015-10-07
    Subject matter details: 2
    Lobbying target types: 2
    Government funding: No
    Employees who lobby: 5
    Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020.
Date Modified: